Search Results - "ULCHAKER, JAMES C."

Refine Results
  1. 1
  2. 2
  3. 3

    Laparoscopic radical cystectomy and continent orthotopic ileal neobladder performed completely intracorporeally: the initial experience by Gill, Inderbir S, Kaouk, Jihad H, Meraney, Anoop M, Desai, Mihir M, Ulchaker, James C, Klein, Eric A, Savage, Stephen J, Sung, Gyung Tak

    Published in The Journal of urology (01-07-2002)
    “…We introduce the operative technique of laparoscopic radical cystectomy and orthotopic ileal neobladder with a Studer limb performed completely…”
    Get more information
    Journal Article
  4. 4

    Radical prostatectomy as primary treatment modality for locally advanced prostate cancer: A prospective analysis by Berglund, Ryan K., Jones, J. Stephen, Ulchaker, James C., Fergany, Amr, Gill, Inderbir, Kaouk, Jihad, Klein, Eric A.

    Published in Urology (Ridgewood, N.J.) (01-06-2006)
    “…Locally advanced prostate cancer is frequently treated with radiotherapy and androgen deprivation because of the greater rate of extracapsular disease and the…”
    Get full text
    Journal Article
  5. 5

    Update on AUA guideline on the management of benign prostatic hyperplasia by McVary, Kevin T, Roehrborn, Claus G, Avins, Andrew L, Barry, Michael J, Bruskewitz, Reginald C, Donnell, Robert F, Foster, Jr, Harris E, Gonzalez, Chris M, Kaplan, Steven A, Penson, David F, Ulchaker, James C, Wei, John T

    Published in The Journal of urology (01-05-2011)
    “…To revise the 2003 version of the American Urological Association's (AUA) Guideline on the management of benign prostatic hyperplasia (BPH). From MEDLINE®…”
    Get more information
    Journal Article
  6. 6
  7. 7
  8. 8

    Cost-effectiveness analysis of six therapies for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia by Ulchaker, James C, Martinson, Melissa S

    Published in ClinicoEconomics and outcomes research (01-01-2018)
    “…To conduct a cost-effectiveness analysis from payers' perspectives of six treatments for lower urinary tract symptoms (LUTS) associated with benign prostatic…”
    Get full text
    Journal Article
  9. 9

    Cost Comparison of Benign Prostatic Hyperplasia Treatment Options by DeWitt-Foy, Molly E., Gill, Bradley C., Ulchaker, James C.

    Published in Current urology reports (01-08-2019)
    “…Purpose of Review To provide an economic context within which to consider treatment options for benign prostatic hyperplasia (BPH). To this end, this review…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Costs of Managing Benign Prostatic Hyperplasia in the Office and Operating Room by Gill, Bradley C., Ulchaker, James C.

    Published in Current urology reports (01-09-2018)
    “…Purpose of Review To review the costs associated with benign prostatic hyperplasia (BPH) management. Specifically, to compare the costs of medical therapy,…”
    Get full text
    Journal Article
  12. 12

    Prognostic Significance of Nondiagnostic Molecular Changes in Urine Detected by UroVysion Fluorescence In Situ Hybridization During Surveillance for Bladder Cancer by Nguyen, Carvell T, Litt, David B, Dolar, Sandra E, Ulchaker, James C, Jones, J. Stephen, Brainard, Jennifer A

    Published in Urology (Ridgewood, N.J.) (01-02-2009)
    “…Objectives To determine the outcomes for patients with nondiagnostic fluorescence in situ hybridization (FISH) (ie, <4 gains of chromosomes 3, 7, or 17 in ≤3…”
    Get full text
    Journal Article
  13. 13

    Comparative Effectiveness of Transurethral Prostate Procedures at Enabling Urologic Medication Discontinuation: A Retrospective Analysis by Sabharwal, Navin C., Shoskes, Daniel A., Dielubanza, Elodi J., Ulchaker, James C., Fareed, Khaled, Gill, Bradley C.

    Published in Urology (Ridgewood, N.J.) (01-12-2019)
    “…To test the hypothesis that transurethral prostate procedures (TUPPs) eliminating tissue result in greater medication discontinuation and lower de novo…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Effect of anatomic, procedural, and dosimetric variables on urinary retention after permanent iodine-125 prostate brachytherapy by Elshaikh, Mohamed A, Angermeier, Kenneth, Ulchaker, James C, Klein, Eric A, Chidel, Mark A, Mahoney, Stephen, Wilkinson, D.Allan, Reddy, Chandana A, Ciezki, Jay P

    Published in Urology (Ridgewood, N.J.) (2003)
    “…To correlate anatomic, procedural, and dosimetric parameters with the rate of intermittent self-catheterization (ISC). The records of 402 patients with a…”
    Get full text
    Journal Article
  16. 16

    Prophylactic urethral stenting with Memokath® 028SW in prostate cancer patients undergoing prostate 125I seed implants: phase I/II study by Chao, Samuel T, Angermeier, Kenneth, Klein, Eric A, Reddy, Chandana A, Ulchaker, James C, Stephenson, Andrew, Campbell, Steven, Ciezki, Jay P

    Published in Journal of contemporary brachytherapy (01-03-2011)
    “…Purpose : To study the feasibility/toxicity of urethral stenting with the Memokath® 028SW stent in patients undergoing prostate implant (PI) for prostate…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20